Bettina Ryll

1.5k total citations · 1 hit paper
25 papers, 844 citations indexed

About

Bettina Ryll is a scholar working on Economics and Econometrics, Oncology and General Health Professions. According to data from OpenAlex, Bettina Ryll has authored 25 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Economics and Econometrics, 7 papers in Oncology and 5 papers in General Health Professions. Recurrent topics in Bettina Ryll's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (5 papers) and Cutaneous Melanoma Detection and Management (5 papers). Bettina Ryll is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Economic and Financial Impacts of Cancer (5 papers) and Cutaneous Melanoma Detection and Management (5 papers). Bettina Ryll collaborates with scholars based in Sweden, Netherlands and France. Bettina Ryll's co-authors include Henrik Lantz, Per Unneberg, Manfred Grabherr, I. Müller, Nagarjun Vijay, Christen M. Bossu, Martin Wikelski, Vittorio Baglione, Jochen B. W. Wolf and Jelmer W. Poelstra and has published in prestigious journals such as Science, Nature Medicine and Journal of Clinical Oncology.

In The Last Decade

Bettina Ryll

24 papers receiving 832 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The genomic landscape underlying phenotypic integrity in the face of gene flow in crows

2014 399 citations Jelmer W. Poelstra, Nagarjun Vijay et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bettina Ryll Sweden	11	329	218	121	119	111	25	844
Ashley J. R. Carter United States	11	309 0.9×	133 0.6×	41 0.3×	141 1.2×	55 0.5×	16	671
Linda K. Martin Australia	17	80 0.2×	105 0.5×	65 0.5×	61 0.5×	63 0.6×	51	1.2k
Alison Davis United Kingdom	14	175 0.5×	187 0.9×	11 0.1×	282 2.4×	132 1.2×	26	1.0k
Katarzyna Bryc United States	12	1.6k 4.9×	484 2.2×	21 0.2×	47 0.4×	82 0.7×	13	2.3k
Kimberly L. Cooper United States	21	268 0.8×	699 3.2×	8 0.1×	132 1.1×	43 0.4×	62	1.5k
Bonnie Cole United States	11	450 1.4×	205 0.9×	7 0.1×	117 1.0×	50 0.5×	53	866
Davide Pettener Italy	25	1.4k 4.4×	394 1.8×	24 0.2×	40 0.3×	22 0.2×	87	2.1k
Richard H. Ward United States	16	327 1.0×	154 0.7×	13 0.1×	83 0.7×	27 0.2×	39	1.1k
Trevor J. Pemberton United States	21	1.1k 3.2×	545 2.5×	17 0.1×	30 0.3×	61 0.5×	37	1.6k
Laura Scheinfeldt United States	18	905 2.8×	337 1.5×	21 0.2×	33 0.3×	23 0.2×	50	1.4k

Countries citing papers authored by Bettina Ryll

Since Specialization

Citations

This map shows the geographic impact of Bettina Ryll's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bettina Ryll with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bettina Ryll more than expected).

Fields of papers citing papers by Bettina Ryll

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bettina Ryll. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bettina Ryll. The network helps show where Bettina Ryll may publish in the future.

Co-authorship network of co-authors of Bettina Ryll

This figure shows the co-authorship network connecting the top 25 collaborators of Bettina Ryll. A scholar is included among the top collaborators of Bettina Ryll based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bettina Ryll. Bettina Ryll is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Subbiah, Vivek, Mohamed A. Gouda, Bettina Ryll, Howard A. Burris, & Razelle Kurzrock. (2024). The evolving landscape of tissue‐agnostic therapies in precision oncology. CA A Cancer Journal for Clinicians. 74(5). 433–452. 35 indexed citations

Doorn-Khosrovani, Sahar Barjesteh van Waalwijk van, Hans Timmer, Karin Verkerk, et al.. (2024). 1550P Addressing uncertainties of clinical value and improving access for newly authorised indications through DRUG-Access Protocol (DAP)-like platforms: Joint collection and evaluation of real-world evidence. Annals of Oncology. 35. S943–S944. 1 indexed citations

Taskén, Kjetil, Edvard Abel, Katarina Steen Carlsson, et al.. (2024). Single point of entry to the European precision cancer medicine trial network PRIME-ROSE.. Journal of Clinical Oncology. 42(16_suppl). e23024–e23024. 2 indexed citations

Gelderblom, Hans, Anders Edsjö, Ulrik Lassen, et al.. (2023). 1711P The DRUP-like clinical trials family: A distributed European trial network for equitable access to precision medicine. Annals of Oncology. 34. S933–S934. 1 indexed citations

Mohyuddin, Ghulam Rehman, Nikita Mehra, Bettina Ryll, & Vinay Prasad. (2022). Control participants of randomised trials: an often forgotten, vulnerable population. The Lancet Haematology. 9(9). e634–e636. 2 indexed citations

Atkinson, Victoria, Caroline Robert, Jean‐Jacques Grob, et al.. (2022). Improved pyrexia-related outcomes associated with an adapted pyrexia adverse event management algorithm in patients treated with adjuvant dabrafenib plus trametinib: Primary results of COMBI-APlus. European Journal of Cancer. 163. 79–87. 15 indexed citations

Ryll, Bettina. (2021). Digitale Gesundheitsanwendungen (DiGA): Patientenzentrierte Gesundheitsversorgung mit disruptivem Potenzial. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz. 64(10). 1207–1212. 7 indexed citations

Delnoij, Diana, et al.. (2021). Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study. Journal of Medical Internet Research. 23(12). e27497–e27497. 4 indexed citations

Sessa, C., Javier Cortés, Pierfranco Conté, et al.. (2021). The impact of COVID-19 on cancer care and oncology clinical research: an experts’ perspective. ESMO Open. 7(1). 100339–100339. 25 indexed citations

10.

Athanasiou, Dimitrios, et al.. (2020). Global Collaborative Social Network (Share4Rare) to Promote Citizen Science in Rare Disease Research: Platform Development Study. JMIR Formative Research. 5(3). e22695–e22695. 10 indexed citations

11.

Ryll, Bettina. (2020). From good to great: what patients can do for your medical research. Nature Medicine. 26(10). 1508–1508. 5 indexed citations

12.

Ryll, Bettina. (2019). No other interest can take precedence — a patient’s perspective on oncology drug development. Nature Reviews Clinical Oncology. 16(8). 461–462. 6 indexed citations

13.

Rodrigues, Manuel, Leanne de Koning, Sarah E. Coupland, et al.. (2019). So Close, yet so Far: Discrepancies between Uveal and Other Melanomas. A Position Paper from UM Cure 2020. Cancers. 11(7). 1032–1032. 47 indexed citations

14.

Makady, Amr, Bettina Ryll, Gilliosa Spurrier, et al.. (2018). Social media as a tool for assessing patient perspectives on quality of life in metastatic melanoma: a feasibility study. Health and Quality of Life Outcomes. 16(1). 222–222. 9 indexed citations

15.

Makady, Amr, Bettina Ryll, Keith R. Abrams, et al.. (2017). Practicalities Of Using Real-World Evidence (RWE) In Comparative Effectiveness Research (CER): Learnings From Imi-Getreal. Value in Health. 20(9). A692–A692.

16.

Aapro, Matti, Rachel Hess, Francesco De Lorenzo, et al.. (2017). All.Can initiative: improving efficiency in cancer care. Annals of Oncology. 28. v395–v395. 1 indexed citations

17.

Geißler, Jan, et al.. (2017). Improving Patient Involvement in Medicines Research and Development: A Practical Roadmap. Therapeutic Innovation & Regulatory Science. 51(5). 612–619. 73 indexed citations

18.

Paolo, Antonello Di, et al.. (2017). Personalized medicine in Europe: not yet personal enough?. BMC Health Services Research. 17(1). 289–289. 33 indexed citations

19.

Poelstra, Jelmer W., Nagarjun Vijay, Christen M. Bossu, et al.. (2014). The genomic landscape underlying phenotypic integrity in the face of gene flow in crows. Science. 344(6190). 1410–1414. 399 indexed citations breakdown →

20.

Sanchez, Sophie, Vincent Dupret, Paul Tafforeau, et al.. (2013). 3D Microstructural Architecture of Muscle Attachments in Extant and Fossil Vertebrates Revealed by Synchrotron Microtomography. PLoS ONE. 8(2). e56992–e56992. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact